Genentech, Inc. (San Francisco, CA, www.genentech.com) has announced the promotions of four vice presidents to senior vice presidents, and the appointment of a new vice president.
Genentech, Inc. (San Francisco, CA, www.genentech.com) has announced the promotions of four vice presidents to senior vice presidents, and the appointment of a new vice president. The four vice presidents promoted to senior vice president include: Markus Gemuend, senior vice president, biochemical manufacturing; Sean A. Johnston, senior vice president and general counsel; Timothy L. Moore, senior vice president, global supply chain; and John Orwin, senior vice president, sales and marketing, biooncology. Also announced was the promotion of Christopher Horan to vice president, planning, distribution, and logistics.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.